News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
149,522 Results
Type
Article (8261)
Company Profile (45)
Press Release (141216)
Section
Business (45545)
Career Advice (141)
Deals (8001)
Drug Delivery (31)
Drug Development (20699)
Employer Resources (12)
FDA (4360)
Job Trends (2701)
News (80223)
Policy (8937)
Tag
Academia (496)
Allergies (25)
Alliances (15613)
Alzheimer's disease (321)
Antibody-drug conjugate (ADC) (28)
Approvals (4362)
Artificial intelligence (29)
Bankruptcy (27)
Best Places to Work (2180)
Biosimilars (59)
Biotechnology (34)
Breast cancer (45)
Cancer (382)
Career advice (123)
Cell therapy (71)
Clinical research (16868)
Collaboration (145)
Compensation (28)
COVID-19 (656)
C-suite (33)
Data (378)
Diabetes (30)
Diagnostics (1055)
Drug discovery (23)
Earnings (15441)
Events (17417)
Executive appointments (90)
FDA (4618)
Funding (111)
Gene therapy (62)
GLP-1 (123)
Government (1433)
Healthcare (2877)
Infectious disease (683)
Inflammatory bowel disease (48)
IPO (3181)
Job creations (603)
Job search strategy (121)
Layoffs (52)
Legal (1437)
Liver cancer (26)
Lung cancer (74)
Lymphoma (27)
Manufacturing (88)
Medical device (2169)
Medtech (2171)
Mergers & acquisitions (4918)
Metabolic disorders (73)
Neuroscience (390)
NextGen Class of 2024 (897)
Non-profit (408)
Northern California (385)
Obesity (27)
Opinion (40)
Patents (28)
People (12015)
Phase I (5213)
Phase II (7053)
Phase III (6189)
Pipeline (179)
Policy (28)
Postmarket research (512)
Preclinical (1986)
Press Release (66)
Radiopharmaceuticals (55)
Rare diseases (62)
Real estate (1400)
Regulatory (6624)
Research institute (459)
Series A (25)
Southern California (401)
Startups (926)
United States (3490)
Vaccines (158)
Date
Today (4)
Last 7 days (28)
Last 30 days (567)
Last 365 days (8903)
2024 (8903)
2023 (9901)
2022 (14512)
2021 (14559)
2020 (13047)
2019 (9072)
2018 (7026)
2017 (8087)
2016 (7297)
2015 (8785)
2014 (6389)
2013 (5138)
2012 (5445)
2011 (5710)
2010 (4996)
Location
Africa (160)
Asia (24967)
Australia (3029)
California (915)
Canada (305)
China (178)
Colorado (31)
Europe (23828)
Florida (90)
Illinois (45)
Indiana (33)
Japan (48)
Maryland (304)
Massachusetts (616)
Minnesota (59)
New Jersey (416)
New York (271)
North Carolina (194)
Northern California (385)
Ohio (29)
Pennsylvania (162)
South America (225)
Southern California (401)
Texas (98)
Utah (25)
Washington State (70)
149,522 Results for "cobra biologics ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Park Ha Biological Technology Co., Ltd. Announces Pricing of $4.8 Million Initial Public Offering
December 26, 2024
·
4 min read
Additional COBRA results: SAR-bisPSMA detects lesions in the 2-millimetre range
Clarity Pharmaceuticals, a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for children and adults with cancer, is pleased to share additional data from its diagnostic 64Cu-SAR-bisPSMA trial, COBRA.
March 8, 2024
·
11 min read
Biotech Bay
Guardant Health Provides Update on COBRA Study, Restates Confidence in MRD Test
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today issued the following statement about the closure of COBRA, a minimum residual disease (MRD) study.
September 1, 2023
·
3 min read
Drug Development
Biond Biologics Announces First Patient Dosed with BND-35 in Phase 1 Clinical Trial
Biond Biologics Ltd. today announced that the first patient has been dosed in a first-in-human clinical trial testing BND-35, a humanized ILT3/LILRB4 antagonist antibody.
June 24, 2024
·
4 min read
Press Releases
AI/ML Innovations Closes Acquisition of Quantum Sciences Ltd.
December 24, 2024
·
8 min read
Press Releases
Portage Biotech Announces Letter of Intent with Immunova for an Option to Acquire iOx Therapeutics, Ltd
December 18, 2024
·
4 min read
Press Releases
WORK Medical Technology Group LTD’s Subsidiary, Hangzhou Shanyou, Showcases Products at MEDICA Trade Fair 2024
November 28, 2024
·
4 min read
Press Releases
AI/ML Innovations to Acquire Quantum Sciences Ltd
December 10, 2024
·
4 min read
Press Releases
Meiji Seika Pharma: Announcement of the Establishment of Local Subsidiary “Taiwan Meiji Pharma Co., Ltd.” in Taiwan
December 25, 2024
·
1 min read
Press Releases
Hepion Pharmaceuticals, Inc. Announces Termination of Merger Agreement with Pharma Two B Ltd.
December 11, 2024
·
3 min read
1 of 14,953
Next
